Inventor · disambiguated record
Andrew John Jennings
Also filed as: JENNINGS ANDREW · JENNINGS ANDREW J · JENNINGS ANDREW JOHN
22 granted patents·21 pending applications·218 citations·filing 1994–2024
95Inventor score
Files withGASHERBRUM BIO INC14TAKEDA SAN DIEGO INC8GANGLOFF ANTHONY R3SMITHKLINE BEECHAM PLC3TAKEDA PHARMACEUTICAL3
Top patents by PatentIndex Score
43 records- 0194US11926626B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Mar 12, 2024·7 cites·23 claims
- 0294US11492365B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Nov 8, 2022·6 cites·15 claims
- 0394US8669249B2Poly (ADP-ribose) polymerase (PARP) inhibitorsBROWN JASON W·Filed 2010·Granted Mar 11, 2014·38 cites·12 claims
- 0493US12221442B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2024·Granted Feb 11, 2025·3 cites·4 claims
- 0593US7928105B2Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-onesTAKEDA PHARMACEUTICAL·Filed 2010·Granted Apr 19, 2011·24 cites·21 claims
- 0692US11897851B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2023·Granted Feb 13, 2024·3 cites·5 claims
- 0791US7169801B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2004·Granted Jan 30, 2007·34 cites·67 claims
- 0887US7642275B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2005·Granted Jan 5, 2010·12 cites·19 claims
- 0984US5905080AAmide and urea derivatives as 5HT1D receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 1994·Granted May 18, 1999·61 cites·8 claims
- 1082US2025115606A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 1180US8124606B2Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-onesGANGLOFF ANTHONY R·Filed 2011·Granted Feb 28, 2012·4 cites·17 claims
- 1280US2025145597A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1379US7381825B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2004·Granted Jun 3, 2008·9 cites·33 claims
- 1477US8450323B2Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazineGANGLOFF ANTHONY R·Filed 2012·Granted May 28, 2013·3 cites·16 claims
- 1575US7375228B2Histone deacetylase inhibitorsTAKEDA SAN DIEGO INC·Filed 2004·Granted May 20, 2008·6 cites·63 claims
- 1675US2023071840A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2022·Application pending·0 cites
- 1772US8822470B2Substituted pyrido[2,3-b]pyrazinesTAKEDA PHARMACEUTICAL·Filed 2013·Granted Sep 2, 2014·1 cites·17 claims
- 1872US8563730B2Pyrazole and fused pyrazole glucokinase activatorsCHERUVALLATH ZACHARIA·Filed 2009·Granted Oct 22, 2013·1 cites·52 claims
- 1971US11926643B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 2067US2025171473A1Phosphorous Containing BCL Inhibitors and Senolytic Compounds and Uses ThereofRUBEDO LIFE SCIENCES INC·Filed 2024·Application pending·0 cites
- 2167US2025171435A1Carbon Linked BCL Inhibitors and Senolytic Compounds and Uses ThereofRUBEDO LIFE SCIENCES INC·Filed 2024·Application pending·0 cites
- 2262US9187497B2Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)GANGLOFF ANTHONY R·Filed 2014·Granted Nov 17, 2015·0 cites·21 claims
- 2361US2023295154A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 2460US2025250269A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 2558US2024366639A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2022·Application pending·0 cites
- 2657US2005159470A1Histone deacetylase inhibitorsSYRRX INC·Filed 2004·Application pending·0 cites
- 2756US7309594B1Crystallization of protein kinase Bα/AKT1TAKEDA SAN DIEGO INC·Filed 2004·Granted Dec 18, 2007·0 cites·4 claims
- 2855US2023391760A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 2954US2012225887A1Glucokinase ActivatorsCHERUVALLATH ZACHARIA·Filed 2012·Application pending·0 cites
- 3053US9139598B2Glucokinase activatorsTAKEDA CALIFORNIA INC·Filed 2013·Granted Sep 22, 2015·0 cites·51 claims
- 3153US2024083886A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 3253US2023322771A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 3352US2016009735A1Glucokinase ActivatorsTAKEDA PHARMACEUTICAL·Filed 2015·Application pending·0 cites
- 3451US2024018102A1Compounds and compositions for treating conditions associated with lpa receptor activityLHOTSE BIO INC·Filed 2021·Application pending·0 cites
- 3550US2023165846A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 3649US5834471AAmide derivatives as 5HT1D receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 1994·Granted Nov 10, 1998·3 cites·8 claims
- 3745US2005137234A1Histone deacetylase inhibitorsSYRRX INC·Filed 2004·Application pending·0 cites
- 3844US7235672B1Probe, assay and kits for detecting 11β-hydroxysteroid dehydrogenase and modulators thereofTAKEDA SAN DIEGO INC·Filed 2004·Granted Jun 26, 2007·0 cites·63 claims
- 3942US2010093767A1Mitotic Kinase InhibitorsTAKEDA SAN DIEGO INC·Filed 2005·Application pending·0 cites
- 4041US2005250829A1Kinase inhibitorsTAKEDA SAN DIEGO INC·Filed 2005·Application pending·0 cites
- 4139US5952325ATricyclic spiro compounds process for their preparation and their use of 5HT1D receptor antagonistsSMITHKLINE BEECHAM PLC·Filed 1995·Granted Sep 14, 1999·3 cites·8 claims
- 4238US2007173527A1Histone deacetylase inhibitorsBRESSI JEROME C·Filed 2007·Application pending·0 cites
- 4334US2008153869A1Kinase InhibitorsBRESSI JEROME C·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew John Jennings files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →